Trial of Aripiprazole in the Treatment of CD in Adolescents

PHASE4CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

November 17, 2004

Primary Completion Date

March 23, 2009

Study Completion Date

March 23, 2009

Conditions
Conduct Disorder
Interventions
DRUG

Aripiprazole

The initial dose depending on the weight of the patient will be as follows: \< 25 kg = 1 mg/d; 25-50 kg = 2 mg/d; 50-70 kg = 5 mg/d; \> 70 kg = 10 mg/d (Data on File, 2003, Bristol-Myers Squibb). Thereafter the dose will be flexible based on response and tolerance for the duration of the 6 week study. All subjects initially received either a 5 or 10 mg/d (7.0 ± 2.6 mg/d) dose of aripiprazole. Thereafter the dose was individualized based on response and tolerance. Maximum dose was 20 mg.

Trial Locations (1)

52242

The University of Iowa Hospitals and Clinics, Iowa City

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Bristol-Myers Squibb

INDUSTRY

lead

University of Iowa

OTHER